Prophylactic nimodipine treatment for cochlear and facial nerve preservation after vestibular schwannoma surgery: a randomized multicenter Phase III trial.

OBJECTIVE A pilot study of prophylactic nimodipine and hydroxyethyl starch treatment showed a beneficial effect on facial and cochlear nerve preservation following vestibular schwannoma (VS) surgery. A prospective Phase III trial was undertaken to confirm these results. METHODS An open-label, 2-arm, randomized parallel group and multicenter Phase III trial with blinded expert review was performed and included 112 patients who underwent VS surgery between January 2010 and February 2013 at 7 departments of neurosurgery to investigate the efficacy and safety of the prophylaxis. The surgery was performed after the patients were randomly assigned to one of 2 groups using online randomization. The treatment group (n = 56) received parenteral nimodipine (1-2 mg/hr) and hydroxyethyl starch (hematocrit 30%-35%) from the day before surgery until the 7th postoperative day. The control group (n = 56) was not treated prophylactically. RESULTS Intent-to-treat analysis showed no statistically significant effects of the treatment on either preservation of facial nerve function (35 [67.3%] of 52 [treatment group] compared with 34 [72.3%] of 47 [control group]) (p = 0.745) or hearing preservation (11 [23.4%] of 47 [treatment group] compared with 15 [31.2%] of 48 [control group]) (p = 0.530) 12 months after surgery. Since tumor sizes were significantly larger in the treatment group than in the control group, logistic regression analysis was required. The risk for deterioration of facial nerve function was adjusted nearly the same in both groups (OR 1.07 [95% CI 0.34-3.43], p = 0.91). In contrast, the risk for postoperative hearing loss was adjusted 2 times lower in the treatment group compared with the control group (OR 0.49 [95% CI 0.18-1.30], p = 0.15). Apart from dose-dependent hypotension (p < 0.001), no clinically relevant adverse reactions were observed. CONCLUSIONS There were no statistically significant effects of the treatment. Despite the width of the confidence intervals, the odds ratios may suggest but do not prove a clinically relevant effect of the safe study medication on the preservation of cochlear nerve function after VS surgery. Further study is needed before prophylactic nimodipine can be recommended in VS surgery.

[1]  T. Hadlock,et al.  Nimodipine and acceleration of functional recovery of the facial nerve after crush injury. , 2010, Archives of facial plastic surgery.

[2]  P. Mattsson,et al.  Nimodipine-induced improved survival rate of facial motor neurons following intracranial transection of the facial nerve in the adult rat. , 1999, Journal of neurosurgery.

[3]  G. Gardner,et al.  Hearing Preservation in Unilateral Acoustic Neuroma Surgery , 1988, The Annals of otology, rhinology, and laryngology.

[4]  E. Wijdicks,et al.  Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage , 2010, The Lancet Neurology.

[5]  M. Bäckdahl,et al.  Nimodipine and Microsurgery Induced Recovery of the Vocal Cord after Recurrent Laryngeal Nerve Resection , 2005, The Laryngoscope.

[6]  O. Guntinas-Lichius,et al.  Nimodipine maintains in vivo the increase in GFAP and enhances the astroglial ensheathment of surviving motoneurons in the rat following permanent target deprivation , 1997, Journal of neurocytology.

[7]  P. Mattsson,et al.  Nimodipine Improves Reinnervation and Neuromuscular Function after Injury to the Recurrent Laryngeal Nerve in the Rat , 2007, The Annals of otology, rhinology, and laryngology.

[8]  A. Samii,et al.  Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. , 2006, Journal of neurosurgery.

[9]  C. Strauss,et al.  Neuroprotective Efficacy of Prophylactic Enteral and Parenteral Nimodipine Treatment in Vestibular Schwannoma Surgery: A Comparative Study , 2013, Journal of Neurological Surgery—Part A.

[10]  C. Strauss,et al.  Preservation of Facial Nerve Function after Postoperative Vasoactive Treatment in Vestibular Schwannoma Surgery , 2006, Neurosurgery.

[11]  C. Strauss,et al.  Intraoperative brainstem auditory evoked potential pattern and perioperative vasoactive treatment for hearing preservation in vestibular schwannoma surgery , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  J. Kanzaki,et al.  New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. , 2003, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[13]  A. Gharabaghi,et al.  The impact of hypotension due to the trigeminocardiac reflex on auditory function in vestibular schwannoma surgery. , 2006, Journal of neurosurgery.

[14]  H. Richter,et al.  THE INFLUENCE OF PROPHYLACTIC VASOACTIVE TREATMENT ON COCHLEAR AND FACIAL NERVE FUNCTIONS AFTER VESTIBULAR SCHWANNOMA SURGERY: A PROSPECTIVE AND OPEN‐LABEL RANDOMIZED PILOT STUDY , 2007, Neurosurgery.

[15]  W. Koos.  Criteria for preservation of vestibulocochlear nerve function during microsurgical removal of acoustic neurinomas , 2005, Acta Neurochirurgica.

[16]  P. Mattsson,et al.  Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush , 2001, The Journal of comparative neurology.

[17]  E. Stennert,et al.  Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  J. W. House,et al.  Facial Nerve Grading System , 1985, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[19]  C. Strauss,et al.  Vasoactive treatment for hearing preservation in acoustic neuroma surgery. , 2001, Journal of neurosurgery.

[20]  C. Strauss,et al.  Delayed Facial Nerve Paresis Following Acoustic Neuroma Resection and Postoperative Vasoactive Treatment , 2004, Zentralblatt fur Neurochirurgie.

[21]  C. Scheller,et al.  Nimodipine promotes regeneration of peripheral facial nerve function after traumatic injury following maxillofacial surgery: an off label pilot-study. , 2012, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[22]  M. Samii,et al.  Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. , 1997, Neurosurgery.